CLINICAL TRIALS PROFILE FOR SALAGEN
✉ Email this page to a colleague
All Clinical Trials for Salagen
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00168181 ↗ | Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients | Completed | CancerCare Manitoba | Phase 3 | 2002-04-01 | This is a study to see whether the drug Salagen or salivary gland transfer is better for the prevention of dryness of the mouth in patients with head and neck cancer receiving radiation treatment. |
NCT00168181 ↗ | Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients | Completed | Jewish General Hospital | Phase 3 | 2002-04-01 | This is a study to see whether the drug Salagen or salivary gland transfer is better for the prevention of dryness of the mouth in patients with head and neck cancer receiving radiation treatment. |
NCT00168181 ↗ | Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients | Completed | Newfoundland Cancer Treatment & Research Foundation | Phase 3 | 2002-04-01 | This is a study to see whether the drug Salagen or salivary gland transfer is better for the prevention of dryness of the mouth in patients with head and neck cancer receiving radiation treatment. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Salagen
Condition Name
Clinical Trial Locations for Salagen
Trials by Country
Clinical Trial Progress for Salagen
Clinical Trial Phase
Clinical Trial Sponsors for Salagen
Sponsor Name